The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway.
The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway.
复制标题
DOI:
10.1002/cbic.201500229
复制
发表时间:
2015-09-21
期刊:
影响因子:
--
通讯作者:
Fenical W
中科院分区:
文献类型:
--
作者:
Álvarez-Micó X;Rocha DD;Guimarães LA;Ambrose A;Chapman E;Costa-Lotufo LV;La Clair JJ;Fenical W
The cytotoxic activity of (-)-chlorizidine A, a marine alkaloid containing a unique fusion between a pyrroloisoindolone and dehydropyrrolizine, was explored using a combination of cellular and molecular methods. Our studies began by applying preliminary SAR evidence gathered from semisynthetic bioactivity evaluations, to prepare an active immunoaffinity fluorescent (IAF) probe. This probe was then used to identify two cytosolic proteins, GAPDH and hENO1, as the targets of (-)-chlorizidine A.